Linezolid for the treatment of patients with endocarditis: a systematic review of the published evidence
The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Background Linezolid is a bacteriostatic oxazolidinone antibiotic that has been proven to be effective for the treatment of patients with pneumonia, skin and soft tissue infections, and possibly bacteraemia, due to Gram-positive cocci. However, the drug is sometimes used for the treatment of patients with endocarditis due to Gram-positive cocci resistant to other antibiotics. Methods We carried out a review of the available literature to evaluate whether linezolid is also effective for the treatment of patients with infective endocarditis. Results We identified 23 case reports and 3 case series reporting the experience with 56 patients with endocarditis treated with linezolid. Evaluable data for 33 patients who received linezolid and for whom individual patient data were reported were further analysed. Prosthetic valve infective endocarditis accounted for 25% of the reviewed cases. Methicillin-resistant Staphylococcus aureus and vancomycin-intermediate S. aureus were the most commonly isolated cocci (24.2% and 30.3% of cases, respectively). Linezolid alone was administered to 66.7% of patients while the rest received the antibiotic in combination with rifampicin, gentamicin, fusidic acid or amikacin. A total of 63.6% (21/33) of patients with endocarditis were cured after linezolid administration. The overall and endocarditis-related mortality was 33.3% (11/33) and 12.1% (4/33), respectively. Thrombocytopenia developed in 30.8% (8/26) of patients for whom relevant data were av…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a small number of patients, linezolid was effective therapy of vancomycin-resistant E faecium IE. 174”
Citations
Cites
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Bolger, A. F., Levison, M. E., Ferrieri, P., Gerber, M. A., Tani, L. Y., Gewitz, M. H., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.165564 · Cited by 1,707
Infective Endocarditis in Adults
Mylonakis, E., & Calderwood, S. B. (2001) · New England Journal of Medicine · doi:10.1056/nejmra010082 · Cited by 1,324
Moreillon, P., & Que, Y.-A. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15266-x · Cited by 861
Howden, B. P., Ward, P. B., Charles, P. G. P., Korman, T. M., Fuller, A., Cros, P. D., Grabsch, E. A., Roberts, S. A., Robson, J., Read, K., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/381202 · Cited by 484 · cited 2×
“2006 (4) M 46 RA, AV and MV replacement possible abscess in the mitral-aortic area CoNS VAN, RIF ( 15 ),”
Birmingham, M. C., Rayner, C. R., Meagher, A. K., Flavin, S. M., Batts, D. H., & Schentag, J. J. (2003) · Clinical Infectious Diseases · doi:10.1086/345744 · Cited by 428
Management of infective endocarditis
Habib, G. (2006) · Heart · doi:10.1136/hrt.2005.063719 · Cited by 211
Shorr, A. F., Kunkel, M. J., & Kollef, M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki355 · Cited by 198 · cited 1×
“M 67 DM prosthetic AV VISA VAN ( 32 ) NA 42 died NA none”
Chien, J. W., Kucia, M. L., & Salata, R. A. (2000) · Clinical Infectious Diseases · doi:10.1086/313597 · Cited by 190 · cited 1×
“2000 ( 27 ) NA abdominal aortic repair, DM, ARF NA VRE VAN, ALF (NA) NA 42 cure 1 none”
Rubinstein, E., Isturiz, R., Standiford, H. C., Smith, L. G., Oliphant, T. H., Cammarata, S., Hafkin, B., Le, V., & Remington, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.6.1824-1831.2003 · Cited by 177
Successful Treatment of Vancomycin-Resistant Enterococcus Endocarditis with Oral Linezolid
Babcock, H. M., Ritchie, D. J., Christiansen, E., Starlin, R., Little, R., & Stanley, S. (2001) · Clinical Infectious Diseases · doi:10.1086/319986 · Cited by 113
Endocarditis Caused by Methicillin‐Resistant Staphylococcus aureus:Treatment Failure with Linezolid
Ruiz, M. E., Guerrero, I. C., & Tuazon, C. U. (2002) · Clinical Infectious Diseases · doi:10.1086/342698 · Cited by 98
Dailey, C. F., Dileto-Fang, C. L., Buchanan, L. V., Oramas-Shirey, M. P., Batts, D. H., Ford, C. W., & Gibson, J. K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.8.2304-2308.2001 · Cited by 82 · cited 2×
“Finally, Dailey et al.40 reported that high-dose oral linezolid (50 or 75 mg/kg) had the same effectiveness as vancomycin in reducing bacterial counts on rabbit heart valves and concluded that the effectiveness of linezolid in the treatment of experimental endocarditis is related to trough levels in plasma above the M…”
INFECTIVE ENDOCARDITIS IN ADULTS
&NA; (2002) · Infectious Diseases in Clinical Practice · doi:10.1097/00019048-200201000-00021 · Cited by 80
Chiang, F.-Y., & Climo, M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.9.3002-3004.2003 · Cited by 77
Nasraway, S. A., Shorr, A. F., Kuter, D. J., O'Grady, N., Le, V. H., & Cammarata, S. (2003) · Clinical Infectious Diseases · doi:10.1086/379327 · Cited by 76
Jacqueline, C., Batard, E., Perez, L., Boutoille, D., Hamel, A., Caillon, J., Kergueris, M.-F., Potel, G., & Bugnon, D. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3706-3711.2002 · Cited by 76 · cited 2×
“On the other hand, Jacqueline et al.(39) reported that continuous linezolid infusion resulted in the same reduction of bacterial counts of three MRSA strains as that of vancomycin.”
BackgroundInfluentialHematologic effects of linezolid in young children
Meissner, H. C., Townsend, T. R., Wenman, W. M., Kaplan, S. L., MORFIN, M. R., EDGE-PADBURY, B., NABERHUIS-STEHOUWER, S., & BRUSS, J. B. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000087021.20838.d9 · Cited by 68
Isolated Pulmonic Valve Infective Endocarditis: A Persistent Challenge
Hamza, N. A., Ortiz, J., & Bonomo, R. A. (2004) · Infection · doi:10.1007/s15010-004-3022-3 · Cited by 56 · cited 4×
“et al., 2003 (19) F 52 multiple myeloma native MV VISA VAN (90), RIF ( 14 )”
InfluentialJacqueline, C., Asseray, N., Batard, E., Mabecque, V. L., Kergueris, M.-F., Dube, L., Bugnon, D., Potel, G., & Caillon, J. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.03.013 · Cited by 49
E, P., F, C., D, B., S, S., Nucci Gd, D., P, S., & M, V. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410019345 · Cited by 47 · cited 2×
“DOX ( 17 ) treatment failure 42 cure 6 thrombocytopenia”
BackgroundAng, J. Y., Lua, J. L., Turner, D. R., & Asmar, B. I. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000101784.83146.0c · Cited by 44 · cited 3×
“2003 ( 20 ) M 4 month preterm infant, RDS, bronchopulmonary dysplasia, atrial septal defect native TV VRE faecium none VRE resistant also to Q/D 63 cure—died from respiratory failure 6 none”
InfluentialAndrade-Baiocchi, S., Tognim, M. C. B., Baiocchi, O. C. G., & Sader, H. S. (2003) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(02)00511-4 · Cited by 44 · cited 2×
“PPM, IVCF native TV VISA VAN ( 19 ), RIF, FUS (11)”
Successful Treatment of Corynebacterium striatum Endocarditis with Daptomycin plus Rifampin
Shah, M., & Murillo, J. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1g242 · Cited by 44 · cited 2×
“F 77 DM native AV VISA VAN (20), RIF ( 9 ) NA 7 died NA none”
BackgroundEndocarditis Caused by Staphylococcus aureus with Reduced Susceptibility to Vancomycin
Woods, C. W., Cheng, A. C., Fowler, Jr., Moorefield, M., Frederick, J., Sakoulas, G., Meka, V. G., Tenover, F. C., Zwadyk, P., & Wilson, K. H. (2004) · Clinical Infectious Diseases · doi:10.1086/383027 · Cited by 42 · cited 1×
“2004 ( 18 ) M 63 AICD, non-Hodgkin lymphoma native AV and MV SARV VAN (23) treatment failure 67 cure— died from respiratory failure 4.5 none”
BackgroundInfluentialWareham, D. W., Abbas, H., Karcher, A. M., & Das, S. S. (2006) · Journal of Infection · doi:10.1016/j.jinf.2005.05.022 · Cited by 41
Failure of Linezolid Treatment for Enterococcal Endocarditis
Zimmer, S. M., Caliendo, A. M., Thigpen, M. C., & Somani, J. (2003) · Clinical Infectious Diseases · doi:10.1086/375877 · Cited by 38 · cited 2×
“M 77 COPD native MV MRSA VAN ( 22 ) renal insufficiency and rash 33 improvement— died due to septic shock from Morganella morganii NA NA”
BackgroundSuccessful Treatment of Enterococcus faecalis Prosthetic Valve Endocarditis with Linezolid
Rao, N., & White, G. J. (2002) · Clinical Infectious Diseases · doi:10.1086/342572 · Cited by 38 · cited 2×
“2004 (18) M 63 AICD, non-Hodgkin lymphoma native AV and MV SARV VAN ( 23 ) treatment failure 67 cure— died from respiratory failure 4.5 none”
InfluentialDailey, C. F., Pagano, P. J., Buchanan, L. V., Paquette, J. A., Haas, J. V., & Gibson, J. K. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2655-2658.2003 · Cited by 36 · cited 1×
“On the contrary, the combination of linezolid with rifampicin was not more effective than linezolid alone.(37) In addition, controversial results were reported from three experimental endocarditis models in rabbits that compared vancomycin with linezolid.”
Persistent MRSA Bacteremia in a Patient with Low Linezolid Levels
Sperber, S. J., Levine, J. F., & Gross, P. A. (2003) · Clinical Infectious Diseases · doi:10.1086/367671 · Cited by 34 · cited 1×
“In addition, some authors suggest that in cases of patients with infections caused by resistant Gram-positive cocci the serum levels of linezolid should be monitored in order to avoid suboptimal concentrations and the dosage should be increased accordingly, if the drug is well tolerated.(31) However, none of the ident…”
BackgroundTreatment failure of methicillin-resistant Staphylococcus aureus endocarditis with linezolid
Corne, P., Marchandin, H., Macia, J., & Jonquet, O. (2005) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540500263110 · Cited by 32 · cited 2×
“2005 (8) M 37 RHD, HoE, allergy to b-lactams native MV Streptococcus mitis VAN, GEN ( 5 ) development of rash 43 cure 1 none”
Ravindran, V. K., John, J., Kaye, G., & Meigh, R. E. (2003) · Journal of Infection · doi:10.1016/s0163-4453(03)00012-4 · Cited by 29 · cited 2×
“2004 (12) M 64 HIV (+), Hep C, RT, parathyroidectomy native MV VRE faecium Q/D ( 21 ),”
BackgroundArchuleta, S., Murphy, B. T., & Keller, M. J. (2004) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2004.00059.x · Cited by 28
Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with linezolid
Bassetti, M., Biagio, A. D., Bono, V. D., Cenderello, G., & Bassetti, D. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.12.018 · Cited by 27 · cited 3×
“2005 (5) M 62 asthma native MV MRSA VAN ( 13 ),”
BackgroundInfluentialTreatment of Vancomycin-intermediate Staphylcoccus aureus Endocarditis with Linezolid
Leung, K. T., Tong, M. K. H., Siu, Y.-P., Lam, C. S., Ng, H., & Lee, H. K. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410015907 · Cited by 25
Successful treatment of MRSA native valve endocarditis with oral linezolid therapy: a case report
Nathani, N., Iles, P. B., & Elliott, T. (2005) · Journal of Infection · doi:10.1016/j.jinf.2005.02.016 · Cited by 24 · cited 1×
“Nathani et al., 2005 ( 7 ) F 28 asthma, history of”
BackgroundSouli, M., Pontikis, K., Chryssouli, Z., Galani, I., & Giamarellou, H. (2005) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-005-0023-9 · Cited by 22 · cited 2×
“2005 (5) M 62 asthma native MV MRSA VAN (13), SXT ( 10 )”
BackgroundChopra, P. S. (2003) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/10377_5 · Cited by 20
de Feiter, P. W., Jacobs, J. A., Jacobs, M. J. H. M., Vink, C., & van der Geest, S. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410021018 · Cited by 19
Infective endocarditis treated with linezolid: case report and literature review
Hill, E. E., Herijgers, P., Herregods, M., & Peetermans, W. E. (2006) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-006-0111-5 · Cited by 18 · cited 3×
“2004 (12) M 64 HIV (+), Hep C, RT, parathyroidectomy native MV VRE faecium Q/D (21), SAM ( 4 ),”
BackgroundInfluentialA case of Streptococcus mitis endocarditis successfully treated by linezolid.
Ng, K. H. L., Lee, S., Yip, S., & Que, T. (2005) · PubMed · Cited by 17
Management of Infective Endocarditis
Garg, N. K. (2007) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/12086_22 · Cited by 17
Viale, P., Scolari, C., Colombini, P., Cristini, F., Cadeo, B., & Pagani, L. (2002) · Journal of Chemotherapy · doi:10.1179/joc.2002.14.5.526 · Cited by 10
[Linezolid for the treatment of nosocomial infections after cardiac surgery].
Nv, B., St, K., Vostrikova, T. I., Galina, D. K., & Ng, K. (2003) · PubMed · Cited by 1
Cited by
Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
“In a small number of patients, linezolid was effective therapy of vancomycin-resistant E faecium IE.(174) Birmingham et al(202) reported cure in 17 of 22 courses of therapy (77%) for E faecium IE.”
BackgroundDissemination and publication of research findings: an updated review of related biases
Song, F., Parekh, Hooper, L., Loke, Y., Ryder, J., Sutton, A., Hing, C., Kwok, C., Pang, C., & Harvey, I. (2010) · Health Technology Assessment · doi:10.3310/hta14080 · Cited by 1,039
Linezolid: a review of its properties, function, and use in critical care
Hashemian, S. M., Farhadi, T., & Ganjparvar, M. (2018) · Drug Design, Development and Therapy · doi:10.2147/dddt.s164515 · Cited by 459
“7% of patients, while the rest received a combination therapy.(30) Linezolid has been reported to be very effective in the treatment of ventilator-associated pneumonia and catheterrelated bacteremia, and hence, it is reasonable to use linezolid in the intensive care unit (ICU).”
BackgroundHolland, T. L., Baddour, L. M., Bayer, A. S., Hoen, B., Miro, J. M., & Fowler, V. G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.59 · Cited by 406
Metadata
- Authors
- Falagas, M. E.
- Affiliations
- Henry Dunant Hospital (GR)
- Corresponding author
- Falagas, M. E.
- ORCID
- Falagas, M. E.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-05-30
- Volume
- 58
- Issue
- 2
- Pages
- 273-280
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2132751055
- Semantic Scholar
- 545a043e5b82976db958f7b3ba6dd6b97427306d
- Cited by
- 167
- References
- 43
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 4 · 2023: 10 · 2022: 1 · 2021: 2 · 2020: 4 · 2019: 6 · 2018: 4 · 2017: 6 · 2016: 4 · 2015: 12 · 2014: 11 · 2013: 3 · 2012: 10
- FWCI
- 2.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Antimicrobial Chemotherapy (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Infective Endocarditis Diagnosis and Management
- Health Sciences › Medicine › Surgery › Orthopedic Infections and Treatments
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Keywords
- linezolid, infective endocarditis, oxazolidinones, methicillin-resistant Staphylococcus aureus, vancomycin-intermediate Staphylococcus aureus, prosthetic valve endocarditis, bacteriostatic antibiotics, treatment efficacy, mortality, thrombocytopenia, combination antibiotic therapy
- MeSH terms
- Linezolid, Acetamides, Anti-Bacterial Agents, Endocarditis, Bacterial, Humans, Gram-Positive Bacterial Infections, Oxazolidinones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.